Frequent general practitioner visits are protective against statin discontinuation after a Pharmaceutical Benefits Scheme copayment increase

Karla L. Seaman, Frank M. Sanfilippo, Max K. Bulsara, Tom Brett, Anna Kemp-Casey, Elizabeth E. Roughead, Caroline Bulsara, David B. Preen

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Frequent general practitioner visits are protective against statin discontinuation after a Pharmaceutical Benefits Scheme copayment increase'. Together they form a unique fingerprint.

Medicine and Dentistry